EMARSA 350 MG INJECTION

By Emarsa

Rx

1 Injection in a Vial

Composition icon

Composition

Daptomycin(350mg)

Manufacturer - Sun Pharmaceutical Industries Ltd icon

Manufacturer - Sun Pharmaceutical Industries Ltd

Plot no 107/108,Namli block , Ranipool, East Sikkim 737135

Expires on or after icon

Expires on or after

September, 2025

About EMARSA 350 MG INJECTION

EMARSA 350 MG INJECTION is a powerful antibiotic designed to combat bacterial infections effectively. It specifically targets severe infections affecting the skin, soft tissues, heart, and blood. Administered primarily to critically ill patients in a hospital setting, this medication works by eliminating the bacteria responsible for causing these infections. It should only be administered under the close supervision of a healthcare professional, as the dosage and duration of treatment are determined based on the severity of the individual's condition.

It is crucial to adhere to the prescribed duration of treatment to reap the maximum benefits of EMARSA 350 MG INJECTION. While undergoing treatment, some individuals may experience temporary side effects such as diarrhea, headache, dizziness, rash, and a decrease in blood pressure. These side effects typically diminish as the body adjusts to the medication but should be promptly reported to a doctor if they persist or cause concern.

Prior to initiating treatment with EMARSA 350 MG INJECTION, patients must disclose any allergies to antibiotics or any existing liver or kidney issues to their healthcare provider. Pregnant or breastfeeding individuals should consult their doctor before using this medicine, as precautions may need to be taken to ensure safety. Regular blood tests may be recommended by the healthcare provider to monitor kidney and liver function throughout the course of treatment.

Emarsa 350 Injection 1's, which is another name for EMARSA 350 MG INJECTION, is specifically tailored to address complex bacterial infections, including skin and blood infections like bacteremia and infective endocarditis. Powered by Daptomycin, a cyclic lipopeptide antibiotic, this medication disrupts bacterial cell wall synthesis crucial for bacterial survival, ultimately eradicating the infection. It is important to note that Emarsa 350 Injection 1's functions only against bacterial infections and is not effective for treating viral infections like the flu or common cold.

As with any medication, Emarsa 350 Injection 1's may induce common side effects such as injection site reactions, rash, vomiting, allergic reactions, and fluctuations in blood pressure. It is imperative to have this medication administered by a qualified healthcare professional and not self-administer it. Individuals with known allergies to this antibiotic or other antibiotics should avoid its usage, and caution is advised if one has underlying health conditions like liver problems, kidney disease, or certain muscular conditions. Special care should also be taken regarding the use of birth control pills while on this medication, as non-hormonal birth control methods may be recommended to prevent pregnancy. It is advised to inform the doctor about any persistent diarrhea or pregnancy/breastfeeding status before commencing treatment with Emarsa 350 Injection 1's. Please be aware that this medicine is not intended for use in children under the age of 12 due to limited safety and efficacy data in this population.


Benefits

EMARSA 350 MG INJECTION is a powerful antibiotic that is highly effective in treating severe bacterial infections. With its active ingredient Daptomycin, EMARSA 350 MG INJECTION works by targeting and killing harmful bacteria that can cause serious infections in the body. This broad-spectrum antibiotic is capable of combating a wide range of bacterial strains, providing relief and healing for various types of bacterial infections.


By inhibiting the process of bacterial cell wall synthesis essential for their survival, EMARSA 350 MG INJECTION effectively eliminates the bacteria responsible for the infection. This action not only stops the growth of the bacterial infection but also helps in preventing the development of antibiotic resistance.


When administered by a healthcare professional through injection, EMARSA 350 MG INJECTION starts working quickly to alleviate symptoms and improve the patient's condition. It is essential to follow the prescribed dosage even if there is an improvement in how you feel, as completing the full course of treatment is crucial to ensure all bacteria are eradicated from the body and to prevent any potential recurrence of the infection.


Overall, EMARSA 350 MG INJECTION is a versatile and reliable medication that offers significant benefits in the treatment of severe bacterial infections, providing rapid relief and aiding in the complete eradication of harmful bacteria from the body.


How to use the EMARSA 350 MG INJECTION

To use EMARSA 350 MG INJECTION, you should rely on your doctor or nurse to administer the medicine. Please remember not to attempt to give yourself the injection. A qualified healthcare professional will provide you with a dose of EMARSA 350 MG INJECTION. It is important to note that EMARSA 350 MG INJECTION can be given intravenously (IV) in children above six years of age. If the medicine is administered subcutaneously (SC), it can be used in children above two years of age. Make sure to follow your healthcare provider's instructions carefully and do not self-administer this medication.


Uses of EMARSA 350 MG INJECTION

EMARSA 350 MG INJECTION is specifically designed for treating severe bacterial infections. These infections can be caused by different types of bacteria and may affect various parts of the body. EMARSA 350 MG INJECTION is effective in fighting against these bacterial infections and helping the body to recover. It is an important medication prescribed by healthcare providers to combat serious bacterial infections and improve the overall health of patients.


What conditions EMARSA 350 MG INJECTION treats?

EMARSA 350 MG INJECTION is used to treat bacterial infections, which are caused by harmful bacteria entering and infecting the body. These infections can occur in any part of the body and can lead to symptoms such as fevers, chills, and fatigue. Individuals with weak immune systems or those taking immunosuppressive medications may be more susceptible to bacterial infections. It is important to note that EMARSA 350 MG INJECTION does not work against viral infections like colds and the flu. This medication is specifically used to treat skin and skin structure infections, bacteremia, and right-sided infective endocarditis.


Should you consult a doctor?

If you experience any persistent side effects after receiving EMARSA 350 MG INJECTION, it is important to seek medical attention. Some common side effects include rash, decreased blood pressure, headache, dizziness, and diarrhea. While these side effects are typically temporary and may subside as your body gets used to the medication, if they persist or become bothersome, consulting your doctor is recommended. Additionally, if you have concerns about any side effects or notice symptoms such as breathlessness, abnormal liver function tests, urinary tract infection, or increased creatine phosphokinase (CPK) levels in the blood, it is advisable to contact your healthcare provider promptly. Prior to starting treatment with EMARSA 350 MG INJECTION, inform your doctor about any antibiotic allergies, liver, or kidney issues. Pregnant or breastfeeding individuals should also consult their doctor before using this medication. Regular monitoring of kidney and liver function through blood tests may be necessary during treatment.


Side effects of EMARSA 350 MG INJECTION

When using EMARSA 350 MG INJECTION, some individuals may experience side effects. These effects are usually mild and temporary, as your body gets used to the medication. Common side effects may include a rash, decreased blood pressure, headache, dizziness, and breathlessness. It is also possible to notice abnormal liver function tests, urinary tract infections, diarrhea, and an increased level of creatine phosphokinase in the blood.


Other less common side effects might include nausea, vomiting, stomach pain, and diarrhoea. Some individuals may also experience dizziness, difficulty breathing, hypotension, chest pain, sore throat, increased sweating, and reactions at the injection site. If you notice any of these side effects and they persist or cause concern, it is advisable to consult your doctor for further guidance.


Safety advice

scroll

liver

EMARSA 350 MG INJECTION is considered safe for use in patients with liver disease. The available data indicates that adjusting the dosage of EMARSA 350 MG INJECTION may not be necessary for patients with liver issues. However, if you have a pre-existing liver condition or a history of liver disease, it is important to inform your doctor before starting the medication. Your doctor may choose to adjust the dosage of EMARSA 350 MG INJECTION or recommend a different treatment option based on your specific liver condition. It is crucial to follow your doctor's guidance to ensure safe and effective use of this medication.

scroll

kidney

EMARSA 350 MG INJECTION should be used cautiously in patients with kidney issues. Dose adjustment may be necessary, so always consult your doctor before using this medication. Your doctor will evaluate and decide if the benefits outweigh the potential risks for your condition.

scroll

alcohol

While using EMARSA 350 MG INJECTION, it is advised to avoid consuming alcohol as it may worsen your condition. No harmful side effects are observed when alcohol is consumed with this injection.

scroll

driving

When taking EMARSA 350 MG INJECTION, be cautious about driving or using machinery due to potential dizziness and drowsiness caused by the medication. It is advisable to refrain from such activities to ensure safety.

scroll

pregnancy

EMARSA 350 MG INJECTION is generally safe during pregnancy based on animal studies. Limited human studies are available, so it should only be used if necessary. Inform your doctor if pregnant or planning a pregnancy before using.

scroll

breastfeeding

EMARSA 350 MG INJECTION is likely safe during breastfeeding based on limited human data showing minimal risk to the baby. It is advised to only use this medication while breastfeeding if essential, so consult your doctor beforehand.


Consumption warning before consuming EMARSA 350 MG INJECTION

Before using EMARSA 350 MG INJECTION, consider the following warnings. Avoid this injection if you’re allergic to it or other antibiotics. Be cautious if you have liver issues, kidney disease, myasthenia gravis, myopathy, rhabdomyolysis, eosinophilic pneumonia, neuropathy, arrhythmia, or electrolyte imbalance. Notify your doctor if you’ve experienced prolonged diarrhea. Do not take anti-diarrheal medication without consulting your doctor. EMARSA 350 MG INJECTION is not suitable for treating pneumonia or left-sided infective endocarditis. It may reduce the effectiveness of birth control pills; discuss non-hormonal options with your doctor. Inform your doctor if you’re pregnant or nursing, as this medication may not be suitable. It's not recommended for children under 12 years old due to limited safety data.


Disease interactions

EMARSA 350 MG INJECTION should not be given to patients with specific health conditions. It is not suitable for individuals with renal dysfunction, liver disease, myopathy, peripheral neuropathy, rhabdomyolysis, and those undergoing hemodialysis. Patients with these conditions should avoid using EMARSA 350 MG INJECTION.


What if you forgot to take EMARSA 350 MG INJECTION?

If you happen to miss a dose of EMARSA 350 MG INJECTION, it is important to consult your doctor. It is always advisable to follow your prescribed treatment schedule diligently to ensure the best possible outcomes. If you realize you have missed a dose, do not attempt to double up on the next dose to make up for it. Instead, reach out to your healthcare provider for guidance on how to proceed. Your doctor will be able to provide you with specific instructions tailored to your individual circumstances. Remember, it is always better to seek professional advice when it comes to missed doses to ensure the effectiveness and safety of your treatment.


Related lab tests

When using EMARSA 350 MG INJECTION, it is important to monitor your health through certain lab tests. One key test to consider is the Complete Blood Count (CBC). This test provides valuable information about different components of your blood, such as red blood cells, white blood cells, and platelets. By analyzing the results of a CBC, healthcare providers can assess your overall health and detect any potential issues, such as anemia or infections. In addition to the CBC, other important lab tests to consider in relation to EMARSA 350 MG INJECTION include liver function tests, renal function tests, and electrolyte levels. These tests help ensure that your body is responding well to the medication and can help identify any potential side effects. Regular monitoring through these lab tests is crucial to maintaining your health while using EMARSA 350 MG INJECTION.


Additional Information

Habit FormingNo
Chemical ClassLipopeptides
Therapeutic ClassANTI INFECTIVES
Action ClassCell membrane active agent

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

3950

Inclusive of all taxes

Content verified by

chevron-right

Dr. Gowri Kulkarni

MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)

Last update on 01-Oct-2024